US Patent 11104654 Derivatives of sobetirome
Patent 11104654 was granted and assigned to Oregon Health & Science University on August, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+92 characters)
Article
Patent abstract
Ester derivatives of sobetirome with enhanced CNS distribution are disclosed.
Edits on 7 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
111046540
Date of Patent
August 31, 2021
0Patent Application Number
201907120
Date Filed
July 12, 2019
0Official Website
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
0
Current Assignee
0
Patent Jurisdiction
Patent Number
111046540
Date of Patent
August 31, 2021
0Patent Application Number
201907120
Date Filed
July 12, 2019
0Official Website
Edits on 19 May, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 9 Sep, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 11104654 Derivatives of sobetirome
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11104654
Date of patent
August 31, 2021
Patent application number
20190712
Date Filed
July 12, 2019
Find more entities like US Patent 11104654 Derivatives of sobetirome
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.